Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02660996
Other study ID # 5857
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2016
Est. completion date August 14, 2017

Study information

Verified date July 2019
Source Advocate Health Care
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this observational study is to assess the effectiveness of the Advocate Lutheran General Survivorship Center's Programs by measuring the following outcomes of interest on participating patients:

1. Quality of life

2. Distress level

3. Satisfaction with the Survivorship Program

General Hypothesis: Patients who participate in at least four classes in a two month period will have higher scores on the post-class satisfaction, quality of life, and distress surveys compared to their pre-class surveys.


Description:

- If a patient agrees to participate, written consent will be obtained by the study coordinators. Before the start of the first class at the Survivorship Center and after the patients have signed the consent and HIPAA authorization forms, patients will fill out three questionnaires. These include the standardized RAND 36 Health Survey, the Distress Thermometer, and a pilot survey regarding expectations and satisfaction with the Survivorship Program.

- The RAND-36 survey is a form that includes 36 questions and asks how patients feel their illness has impacted them and their lifestyle with scoring as noted. Pre-coded numeric values are recoded per the scoring key. They are scored so that a high score means patient is in better health, 0 being the worst and 10 being the best. Scores represent the percentage of total possible score achieved. Items in the same scale are averaged together to create the 8 scale scores. Missing data is not taken into account. The RAND 36-Item Health Survey 1.0 has been validated in previous studies. According to the VanderZee's study (1996), it was shown that the "internal consistency of the instrument was high with high convergent validity."

- The Distress Thermometer (DT) tool asks patients 39 questions about practical, family, emotional, religious, and physical problems in a "yes" or "no" format. A "yes" will scored as 0 and a "no" will be scored as 1. Therefore, the lower the stress level, the higher the score. The scores will be added for a total score. If the patient does show a high level of distress with a score above 12 on the Distress Thermometer after the four classes at the Survivorship Center, we will refer the patient back to his or her physician for further guidance and possible counseling.

- The Expectation Survey consists of eight questions that ask patients about their expectations for what they want/hope to get out of the Survivorship Program. Patients will rank their answers from 1 - 5 based on how much they agree with the statement (1 being not at all, 5 being very much). The scores for each eight questions will then be averaged.

- The Satisfaction Survey is also an eight question form that is much like the Expectation Survey. Patients will also indicate how satisfied with they are with the classes/courses at the Survivorship Center. The same scaling as above (1-5; 1 being not all agreeing with the statement and 5 being very much) with be used. These two surveys will be pilot tested for content relevance and readability level with current patients. Editions will be made as necessary. There will also be an open ended question at the end to ask patients what they would add to the classes to make them more beneficial.

- Participants will be asked to complete the Rand-36 SF, Distress Thermometer, and Satisfaction Survey after attending at least four Survivorship classes in a two month period.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date August 14, 2017
Est. primary completion date March 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - Inclusion Criteria

- Patients older than 18 years of age, any gender, and any race

- Newly diagnosed with any type of cancer and now seeing one of the oncologists at the Advocate Lutheran General Hospital's Center for Advanced Care

- Patients new to the Survivorship Center or only visited once

- Must attend at least four classes in a two month period (any class, any time, any day)

- Able to consent

- English speaking patient

- Exclusion Criteria

- Not a newly diagnosed cancer patient

- Patients under the age of 18

- Pregnant patients

- Prisoners

- Unable to consent

- Non - English speaking patient

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Advocate Lutheran General Hospital Park Ridge Illinois

Sponsors (1)

Lead Sponsor Collaborator
Advocate Health Care

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life Questionnaire that includes 36 questions and asks how patients feel their illness has impacted them and their lifestyle with scoring as noted. 6-8 months
Secondary Distress level The tool asks patients 39 questions about practical, family, emotional, religious, and physical problems in a "yes" or "no" format. A "yes" will scored as 0 and a "no" will be scored as 1. Therefore, the lower the stress level, the higher the score. The scores will be added for a total score. 6-8 months
Secondary Satisfaction with the Survivorship Program Questionnaire that includes 8 questions that indicate how satisfied the patients are with the classes offered at the Survivorship Center. 6-8 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients